Audited Financial Results for the Period Ended 30 April 2026

Delta Gold Technologies raised £5.2 million from incorporation through 30 April 2026 and reported cash of £3,495,344 and net assets of £3,797,401 at that date, with no borrowings. Cash stood at £3,150,706 on 30 September 2026 after the company received £446,114 from warrant exercises.

Analysis

The balance-sheet snapshot is mildly reassuring, but it does not establish that DGQ has a viable operating business: the release provides no revenue, operating cash flow, expenditure, project milestones or cash-use detail. Because the reported period runs only from incorporation, it is not a meaningful year-on-year performance read. The later cash figure is a liquidity update, not evidence of operating progress; warrant exercise adds cash while increasing the share count, with the net equity impact dependent on exercise terms and dilution.

Near term, this is unlikely to support a durable re-rating without evidence on deployment of capital and measurable milestones. Over the next 1–3 months, audited cash-flow detail, post-period spending, warrant terms and any operational update are the key catalysts. Over 6–18 months, the central risk is that cash is consumed before the company demonstrates commercial traction or secures further funding. The absence of borrowings limits immediate creditor risk, but does not resolve runway or future dilution.

Contrarian read: investors may treat cash and a clean debt line as downside protection, but for a small, early-stage issuer, cash is only a buffer; its value depends on burn rate, execution and access to capital. There is not enough information here to underwrite an outright directional trade.

Key Decisions for Investors

• No trade on the release alone; avoid extrapolating the cash balance into a valuation or runway estimate without operating cash-flow and expenditure data.
• Put DGQ on a diligence watchlist: verify cash-flow statement, current-period burn, intended use of funds, warrant strike prices, expiry dates and shares issued on exercise.
• If considering exposure, size it as a speculative, liquidity-sensitive position and require a concrete operating milestone before adding; warrant exercises can support cash while diluting existing holders.
• Thesis is weakened if subsequent filings show rapid cash depletion, repeated equity issuance, or no verifiable commercial progress; it improves only with disclosed milestones and a credible funding runway.